Table 3.
Unadjusted and Adjusted risk estimated of having Head and Neck Cancer by NSAID use categories.
| Cases/Controls | OR1 | 95% CI | P-value* | Cases/Controls | OR2 | 95% CI | P-value* | |
|---|---|---|---|---|---|---|---|---|
| NSAID use | ||||||||
| Never | 25/10 | 1.00 | 25/10 | 1.00 | ||||
| Ever | 46/61 | 0.25 | (0.09, 0.67) | .01 | 44/59 | 0.31 | (0.11, 0.88) | .03 |
| Never | 25/10 | 1.00 | 25/10 | 1.00 | ||||
| Occasional | 27/24 | 0.37 | (0.13, 1.04) | .06 | 26/23 | 0.45 | (0.15, 1.34) | .15 |
| Daily | 19/37 | 0.12 | (0.04, 0.42) | .001 | 18/36 | 0.14 | (0.04, 0.54) | .004 |
| Aspirin Use | ||||||||
| Never User | 15/6 | 1.00 | 15/6 | 1.00 | ||||
| Daily Aspirin Use | 10/19 | 0.10 | (0.01, 0.78) | .03 | 10/19 | 0.15 | (0.02, 1.3) | .09 |
*P-values were computed using conditional logistic regression.
OR1: Unadjusted Odds Ratio; OR2: Odds Ratio after adjusting for educational level and marital status.